Olfactory dysfunction and cognitive impairment in patients with Parkinson’s disease
DOI:
https://doi.org/10.31157/an.v19i4.58Keywords:
cognition, Parkinson´s disease, SS-16, MoCAAbstract
Olfactory deficit has been described in some neurodegenerative diseases as well as in normal aging. There is pathological and biochemical evidence suggesting that hyposmia might be more severe in subjects with cognitive dysfunction. Objective: the association between olfactory dysfunction and cognitive impairment in mexican Parkinson’s disease (PD) patients is analyzed. Material and methods: a cross-sectional and analytic study with consecutive patients was carried out. The “sniffin’ sticks” (SS-16) testing and Montreal Cognitive Assessment (MoCA) were applied to all patients. Results: a total of 104 patients were included (64.4% male). An olfactory deficits was found in 82.9% of the sample. Additionally, 47.1% of the patients scored less than 26 points in Montreal Cognitive Assessment. No correlations was found between the total SS-16 score and the total MoCA score. When analyzing individual domains a weak correlation was found between lower scores in both tests (r=0.24, p=0.04). Conclusions: we did not found a relation between the presence of olfactory dysfunction and global cognitive function. A significant relation between olfactory deficit and visuospatial/executive dysfunction was noted.Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2014 Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez
This work is licensed under a Creative Commons Attribution 4.0 International License.
September 2022-present © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.
January-September 2022 © The authors. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.
January 2014-December 2021 © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.